Sankalpa’s vision is to serve global sustainability by designing and manufacturing biotechnology, including automated micro-ecologies, for tapping the unlimited potential of algae and other microorganisms to meet ever-increasing human needs for clean energy, food, medicine, water and CO2 sequestration .
Sankalpa’s industrial mission is to lead the global market in the production of equipment, photo-reactors and versatile extraction machinery, utilizing high-efficiency, symbiotic processing systems in order to most cost-efficiently produce and extract essential products including fuel, pharmaceuticals, foods, nutritional supplements, fertilizers, fishmeal and cosmetics.
In so doing we will create a profitable and environmentally responsible means toward maintaining stable resources for the future of humanity, and toward restoring our planetary environment for future generations.
Sankalpa will begin its first phase by exploring super efficient growth and extractions systems for high-demand products from micro-algae to meet established markets for algae products - including fish feed, Omega 3 market, Spirulina proteins, pharmaceuticals and cosmetics. During this phase significant R&D for Phase 2 biofuel photoreactors.
Our second phase will focus on expanding our growth and extraction systems to anticipate and lead emerging markets for algae products, including the introduction of advanced photoreactors and extraction systems for biofuels, high value nutrients, pharmaceuticals and industrial chemicals.
Our third phase is to create an industrial revolution using high-speed systems, next generation IT and ultra-cognitive information graphics for applied biotechnology , thus lowering costs of production to a fraction of existing costs, resulting in more basic resources for more people and a reduction of demand upon our otherwise endangered global natural resources.
300,000 strains of algae offer a superabundance of nutrients and chemicals -a virtually unlimited potential for producing core products for humanity
Algae produce 100 times more oil per acre than traditional food oilseed crops such as soy etc. Algae produces 4,000 -15,000 gallons of oil per acre per year versus 50 gallons per acre for soy, or approximately 26 gallons per hectare
Raw algae can be processed to make biofuel, the renewable equivalent of petroleum, and refined to make gasoline, diesel, jet fuel, and chemical feedstocks for plastics and drugs.
As a result of current high oil prices, depleting fossil oil reserves and growing concerns about increased levels of atmospheric carbon dioxide, algae have emerged as one of the most promising sources for energy and nutrient production.
The process of industrial scale organism growth in photo-reactors and automated growth chambers is non-polluting and non-toxic, can be scaled up, offers a renewable energy supply and aids in carbon sequestration and the mitigation of climate change.
At the same time, demand is increasing rapidly for high-value algae based nutritional and pharmaceutical products, offering a lucrative base for launching algae/microorganism and biotechnology start-ups.
Algae Financial Forecast
In August, 2010, Global Information released a new market research report, Algae Biofuels Production Technologies Worldwide, in which they project that the total algae biofuels production technologies market (including cultivation technology sales, harvesting, extraction and fuels production facilities) will reach $1.6 billion in 2015.
According to the study …
“ Starting at an estimated $271 million market size for 2010, this increase is significant and underscores that this is a quickly changing and evolving industry, expected to show an annual growth rate of nearly 43 percent.”
“ If we were to replace all of the diesel that we use in the United States, with an algae derivative, we could do it on an area of land less than one half of 1% of the current farm land that we now use.”
Douglas Henston, Pres. Solix Algae Fuels
Investing In the Future of Fuel
In 2007, $32 million in venture capital was pumped into businesses working on algae fuel.
In 2008, that number reached $184 million worldwide, according to Cleantech Network, which tracks environmental industries.
In 2007 Shell Oil formed Cellana, a joint venture with HR Biopetroleum, which has established an open-pond salt water algae facility in Hawaii specializing in native local species .
In September, 2008, Bill Gates' Cascade Investment and three other companies gave a total of $100 million to Sapphire Energy, a San Diego company producing fuel from algae and other microorganisms.
ExxonMobil: $600 Million
On July 15, 2009, Exxon announced a 600 million dollar investment into algae biofuel research. The research facility is based at partner Synthetic Genomics headquarters, and opened on July 14, 2010 in La Jolla, California.
Algae are a rich and varied source of pharmacologically active natural products and nutraceuticals. The major products currently being commercialized or under consideration for commercial extraction include carotenoids, phycobilins, fatty acids, polysaccharides, vitamins, sterols, and biologically active molecules for use in human and animal health.
Algae yield omega-3 fatty acids, proteins and oils at more profitable margins than other methods of production.
Common species of nutritional supplements include Spirulina, Chlorella and Duniella
Algae extracts are used for health supplements, pharmaceuticals, soaps, lotions, protein bars, shakes, and beauty products.
Nutraceuticals per Kilo
According to BioCentric, which has invested $600,000 in its line of algae nutraceuticals:
Haemaotoccocus has a current market value of $341 per kilogram,
Chlorella clocks in at $44 per kilo and
Spirulina sells for $20 per kilo
Dow Chemical's Steve Gluck notes major opportunity in the chemical industry for algae compared to biofuels .
"To get into the algae market, I think you might have to capture the chemical sector based on how much algae feedstock is needed in the chemical industry compared to the fuel refineries," said Gluck. "Chemicals need a pure material that algae can produce while fuels can have blended components.
Sankalpa and the Future of Biotechnology
India and the Approaching Biotechnology Era
Sankalpa aims to place biotechnology in the forefront of the next industrial revolution, foreseeing that India will take its position at the head of a massive, global concerted effort in microbiology and basic resource production.
India’s natural lead in biotechnology will bring more students to biotechnology colleges in India, increasing endowments for research, new laboratories and equipment.
Jobs in biotechnology will be in demand at higher international wages for graduates as biotechnology takes its place in the center of the coming global industrial revolution.
University and Institutional Alliances
In order to most efficiently launch our efforts, Sankalpa currently seeks mutually beneficial relationships with scientific institutions in India in order to optimize our start-up phase and to build relationships for future efforts.
Such win-win relationships will result in a range of significant future benefits to participating universities and scientific institutions, as well as increased general industrial demand for biotechnology.
Future Benefits To Participating Institutions
Access to Sankalpa biotechnology facilities
Access to Sankalpa biological data
Access to Sankalpa equipment via a range of service and provider agreements
Access to remote Sankalpa bioinformatics database
Access to “Brainshare” - Engineering Services for design of custom lab equipment for research
Access to Biotechnology Equipment
Participating scientific institutions will have access to:
Custom biotechnology for universities and scientific institutions built “at cost”.
Engineering partnerships in designing biotechnology with universities and scientific institutions
Current Status: Preparing Start-up Phase
Sankalpa has recruited over 75 Indian scientists and engineers, pending seed investment
We are currently recruiting core scientific institutions and upper management
Design underway of industrial biotech vision
Business plan in development
Research and outreach to potential investors
Sankalpa has established available land and agreements in Latin America for R&D partnerships in food and fuel production.
The current global crisis demands innovative and rapid solutions. Clearly, governments are behind schedule. The burden now rests upon the global citizenry, and upon the very best of our scientific institutions to create innovative means to recuperate our resources and to create a stable society and environment. Clearly, India is well-blessed with abundant resources in terms of its intellectual and scientific prowess in the fields of engineering, chemistry, IT and biotechnology. We are therefore honored to open our vision, and our first conferences in India, and to invite Vaze College to participate in the launching of Sankalpa and in the birth of what we believe will become the next industrial revolution.
We would like to take this opportunity to thank our friends and colleagues at Vaze College for their kind hospitality and attention.
We look forward to working together toward a bountiful and beneficial future.